Introducing Clara Biotech's proprietary
Exosome Isolation Platform:
Clara offers a scalable solution that makes it possible to isolate
any exosome sub-type from any biofluid with ease, and can
accommodate any volume needs.
Our technology overcomes the limitation of current isolation platforms, giving you back a high yield of viable, pure exosomes.
Ready to do more with less?
Stop waiting on the centrifuge. Send us your samples and we'll get them back to you
within 1-2 weeks.
Our platform offers novel, high specificity isolation at industry leading quality and yield standards greater than 90%.
No more EV and protein contamination - just clean, repeatable results everytime.
Our services are tailored uniquely to each individual's needs and budget.
News & Updates
CLARA BIOTECH IS JOINING THE FIGHT AGAINST COVID-19 Read more about our efforts in the press release below!
Clara COVID19 Therapy Release
Local biotech firm seeks to advance novel
exosome isolation-based therapy for COVID-19
into clinical trials